Pfizer developing booster THIRD shot. YEARLY shots required going forward

Sharing is Caring!
  • Pfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.
  • Clinical studies could begin as early as August, subject to regulatory approvals.
  • Executives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.

Pfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.

See also  Coming soon - monthly COVID shots - it’s a cure for long COVID they say.

The companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the “highest levels” of protection against all currently known variants, including delta, they are “remaining vigilant” and developing an updated version of the vaccine.

See also  Pfizer Vaccine Fails Against the Delta Variant

“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.

www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html

 

659 views

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.